高危成人型软组织肉瘤的围手术期化疗与区域热疗
成人型软组织肉瘤高危患者存在局部复发和远处转移风险,年龄、肿瘤部位、组织学亚型、大小和分级是最重要的独立不良预后因素。肉眼完整切除是主要治疗手段, extremities或躯干可联合术前或术后放疗,腹膜后需间室切除且预后更差、放疗无证实价值。围手术期化疗针对微转移灶,新辅助化疗可尽早干预远处转移风险,报道缓解率高达30%,可能提高可操作性并减少术中肿瘤细胞播散,但存在早期进展风险。优化多模式策略包括化疗、区域热疗和免疫治疗药物已显示可改善高危患者生存。
要点
- 高危成人型软组织肉瘤需综合评估年龄、部位、亚型、大小和分级。
- 围手术期化疗可针对微转移灶,新辅助化疗报道缓解率高达30%。
- 区域热疗可局部增强化疗效果并诱导免疫,多模式策略改善高危患者生存。
核心结论
- 围手术期化疗联合区域热疗的多模式策略可能改善高危成人型软组织肉瘤患者的生存。
研究设计与样本
- 本文聚焦于已发表的随机研究数据,探讨围手术期化疗及区域热疗在高危成人型软组织肉瘤中的应用。
主要发现
- 新辅助化疗报道缓解率高达30%,可能提高可操作性并减少术中肿瘤细胞播散,从而降低局部复发率。
- 围手术期化疗存在潜在早期肿瘤进展风险,可能抵消其获益。
- 包含化疗、区域热疗和免疫治疗药物的优化多模式策略已显示可改善高危患者生存。
关键数值与推荐
- 年龄、肿瘤部位、组织学亚型、肿瘤大小和分级被确定为最重要的独立不良预后因素。
- 肉眼完整肿瘤切除是主要治疗手段, extremity或躯干部位可联合术前或术后放疗。
- 腹膜后部位需间室切除,预后更差,放疗无证实价值。
临床怎么用
- 对高危成人型软组织肉瘤患者,应评估围手术期化疗联合区域热疗的多模式策略以改善生存。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
A group of patients with adult-type soft tissue sarcoma is at high risk of local recurrence and distant metastases. Age, tumour site, histological subtype, tumour size and grade have been identified as the most important independent adverse prognostic factors. Macroscopically complete tumour resection is considered as the mainstay of treatment with the addition of preoperative or postoperative radiotherapy for extremity or trunk localisation. Retroperitoneal localisation requires compartmental resection and is associated with a worse prognosis. Here, radiotherapy is of no proven value. Perioperative chemotherapy is considered to treat micrometastatic disease not detectable at the time of diagnosis. The neoadjuvant application gives the risk of distant metastasis the greatest importance as therapy is carried out at the earliest possible time, whereas adjuvant chemotherapy is delayed by surgery and the necessary wound healing. With reported response rates up to 30%, both the operability may be improved and the risk of intraoperative tumour cell dissemination may be reduced, resulting also in reduced local relapse rates. However, the potential risk of early tumour progression may counteract this benefit. Optimised strategies with multimodality approaches including chemotherapy, regional hyperthermia (RHT) and immunotherapeutic agents have been shown to improve survival in high-risk patients. Here, we focus on the data from available randomised studies investigating the use of perioperative chemotherapy in patients with high-risk adult-type soft tissue sarcoma, including the use of RHT for local enhancement of chemotherapy effect and immune induction.
引用
- Lindner LH, Blay JY, Eggermont AMM, et al. Perioperative chemotherapy and regional hyperthermia for high-risk adult-type soft tissue sarcomas. Eur J Cancer. 2021. PMID: 33684876. doi:10.1016/j.ejca.2021.02.002
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。